We are live on ! Find out more
AXSM icon

Axsome Therapeutics
AXSM

244 hedge funds and large institutions have $3.12B invested in Axsome Therapeutics in 2023 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 70 increasing their positions, 88 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

92% more call options, than puts

Call options by funds: $79.2M | Put options by funds: $41.4M

83% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 24

30% more funds holding in top 10

Funds holding in top 10: 10 → 13 (+3)

18% more capital invested

Capital invested by funds: $2.65B → $3.12B (+$473M)

8% more funds holding

Funds holding: 226 → 244 (+18)

2.6% more ownership

Funds ownership: 80.28% → 82.88% (+2.6%)

20% less repeat investments, than reductions

Existing positions increased: 70 | Existing positions reduced: 88

Holders
244
Holders Change
+18
Holders Change %
+7.96%
% of All Funds
3.56%
Holding in Top 10
13
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+30%
% of All Funds
0.19%
New
44
Increased
70
Reduced
88
Closed
24
Calls
$79.2M
Puts
$41.4M
Net Calls
+$37.9M
Net Calls Change
+$18.3M

Top Buyers

1
Morgan Stanley
Morgan Stanley
New York
+$62.9M
2
PA
Perceptive Advisors
New York
+$37.2M
3
Millennium Management
Millennium Management
New York
+$27.2M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$20.4M
5
BlackRock
BlackRock
New York
+$20.4M

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$65.3M
2
NIP
Nicholas Investment Partners
California
-$20.9M
3
SCM
Soleus Capital Management
Connecticut
-$16.6M
4
Citadel Advisors
Citadel Advisors
Florida
-$13.8M
5
BI
BVF Inc
California
-$10M
Name Holding Trade Value Shares
Change 		Change in
Stake
LSA
126
Lion Street Advisors
Texas
$950K -$157K -2,350 -16%
UOC
127
UBS O'Connor
Illinois
$949K -$923K -13,813 -54%
YIH
128
Y-Intercept (HK)
Hong Kong
$898K +$754K +11,285 New
EAM
129
Erste Asset Management
Austria
$876K – – –
LPL Financial
130
LPL Financial
California
$827K +$127K +1,896 +22%
QIM
131
Quantitative Investment Management
Virginia
$806K +$678K +10,138 New
State Board of Administration of Florida Retirement System
132
State Board of Administration of Florida Retirement System
Florida
$799K – – –
Principal Financial Group
133
Principal Financial Group
Iowa
$756K +$8.02K +120 +1%
HF
134
HRT Financial
New York
$738K -$244K -3,654 -28%
BMSSC
135
B. Metzler seel. Sohn & Co
Germany
$735K +$70.6K +1,056 +13%
SSA
136
Sierra Summit Advisors
Nevada
$734K +$617K +9,224 New
D.E. Shaw & Co
137
D.E. Shaw & Co
New York
$731K +$614K +9,184 New
ProShare Advisors
138
ProShare Advisors
Maryland
$710K +$84.8K +1,268 +17%
FC
139
FORA Capital
Florida
$709K +$595K +8,907 New
LCM
140
Legato Capital Management
California
$686K – – –
ASRS
141
Arizona State Retirement System
Arizona
$682K -$47.3K -708 -8%
William Blair & Company
142
William Blair & Company
Illinois
$678K -$251K -3,750 -31%
JF
143
Jump Financial
Illinois
$669K +$562K +8,400 New
WS
144
Wedbush Securities
California
$664K +$81.9K +1,225 +17%
AQR Capital Management
145
AQR Capital Management
Connecticut
$663K -$95.7K -1,431 -15%
PA
146
Profund Advisors
Maryland
$662K +$12.1K +181 +2%
OIA
147
OneDigital Investment Advisors
Kansas
$619K -$9.36K -140 -2%
Handelsbanken Fonder
148
Handelsbanken Fonder
Sweden
$613K +$60.2K +900 +13%
MA
149
MONECO Advisors
Connecticut
$596K – – –
GT
150
Glenmede Trust
Pennsylvania
$586K -$56K -838 -10%
4 5
6
7 8

AXSM Hedge Fund Activity: Q4 2023 in Review

244 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Axsome Therapeutics (AXSM) for Q4 2023, worth a combined $3.12B — up 18% from $2.65B a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new AXSM positions and 24 closed out — a net gain of 20 holders — while 70 added to existing stakes and 88 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $62.9M. The largest seller was Fidelity Investments, cutting an estimated $65.3M.

  • 244 institutional investors held Axsome Therapeutics (AXSM) as of Q4 2023, up from 226 in Q3 2023.
  • Funds reported $3.12B of Axsome Therapeutics stock for Q4 2023, up 18% quarter-over-quarter.
  • 44 funds opened new Axsome Therapeutics positions in Q4 2023 and 24 closed out, a net change of +20 holders.
  • The largest Axsome Therapeutics buyer in Q4 2023 was Morgan Stanley, an estimated $62.9M added.
  • The largest Axsome Therapeutics seller in Q4 2023 was Fidelity Investments, an estimated $65.3M sold.

Based on aggregated 13F filings for Q4 2023.